This is an interventional, non-randomized, controlled prospective study to treat HCV in
mono-infected and HIV co-infected individuals and compare cardiovascular risk outcomes to HIV
mono-infected controls. This pilot study will demonstrate whether functional cure of HCV
reduces myocardial injury and risk of cardiovascular disease.
Hepatitis C virus,
human immunodeficiency virus,
cardiovascular disease (cvd),
cardiovascular system diseases,
If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.